Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

19:27 EDT 3rd September 2015 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 848

Extremely Relevant

Mylan introduces Amlodipine and Valsartan tablets in US to treat hypertension

Mylan has introduced Amlodipine and Valsartan Tablets, 5mg/160mg, 5mg/320mg, 10mg/160mg, 10 mg/320mg in the US market.

Relevant

Generic hypertension tablets released by Lupin in U.S.

Lupin Pharmaceuticals has made its Valsartan and Amlodipine tablets available in the U.S.  -More- 

Teva launches generic Exforge tabs

Ryan ChavisTeva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension.    read more

Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report

2015 Global Amlodipine Besylate Industry Research Report of 168 pages now readily available at DeepResearchReports.com database. Dallas, Texas (PRWEB) April 20, 2015 The 2015 Market Research Report on the Global Amlodipine Besylate Industry is a professional and in-depth study on the current state of the global Amlodipine Besylate Market with a focus on the Chinese situation. Major companies inc...

Resistant hypertension? Or failure to take blood pressure correctly?

I recently read a discussion by three hypertension specialists, Drs. Jan Basile, Dominic Sica and David Kountz, on how to treat resistant hypertension. Resistant hypertension is blood pressure that remains above goal despite treatment with three drugs, from different classes, one of which must be a diuretic. 10 to 15 percent of patients with high […]

Researchers boost hypertension treatment using unconventional approach

Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.

Mylan Launches Generic Exforge® Tablets

POTTERS BAR, England and PITTSBURGH, March 31, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Amlodipine and Valsartan Tablets, 5 mg/160 mg, 5 mg/320 mg, 10 mg/160 mg, 10 mg/320 mg, which is the generic version of Novartis' Exforge® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applic...

Brain receptors targeted to treat inflammatory response and human hypertension

According to current statistics, hypertension affects more than 33% of US adults. Despite the availability of several antihypertensive medications, the morbidity and mortality caused by hypertension is on the rise, suggesting the need for investigati...

RI Hospital Pulmonary Hypertension Center earns accreditation

(Lifespan) The Pulmonary Hypertension Center at Rhode Island Hospital is one of the nation's first centers of its kind to be accredited by the Pulmonary Hypertension Association. For those affected by pulmonary hypertension, accreditation assures the...

Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz

Silver Spring, Md. (PRWEB) April 27, 2015 On May 5, people living with pulmonary hypertension (PH) and their loved ones will ask their social media friends around the world to join their fight against a life-threatening disease too often dismissed...

Veterinary medicine European public assessment report (EPAR): Lodipressin, amlodipine, Revision: 0, Refused

The AAPS Journal: Human Health Relevance of Pharmaceutically Active Compounds in Drinking Water

Type: Original PaperIn Canada, as many as 20 pharmaceutically active compounds (PhACs) have been detected in samples of treated drinking water. The presence of these PhACs in drinking water raises important questions as to the human health risk posed...

Hypertension: Arteriovenous anastomosis—next panacea for hypertension?

The ROX CONTROL HTN study demonstrated the efficacy of arteriovenous coupler therapy in patients with resistant hypertension. However, one-third of the patients developed late ipsilateral venous stenosis, which required venoplasty or stenting. Future...

Pharmacists help patients with hypertension

If you have hypertension, it pays to include a pharmacist in a medical care team.

Heavy Drinking May Cause More Strokes Than Hypertension Does in Mid-Life

Research has shown that drinking two or fewer alcoholic beverages a day may be beneficial for men’s hearts. A new study suggests that danger could be a heartbeat away: more than two drinks a day in middle age may raise men’s stroke risk more than hypertension (high blood pressure, HBP) or diabetes does.

Improving the detection of preclinical organ damage in newly diagnosed hypertension: nocturnal hypertension versus non-dipping pattern

New research: Stroke risk and too much sleep; genes that make the body salt-sensitive

High blood pressure, or hypertension, affects one third of—or 70 million—US adults1, and the healthcare costs associated with treating the disease are approximately $46 billion2. From May 15 - 19, 2015, members of the medical community from aroun...

Hypertension: RGS5 as a mediator of gestational hypertension

Two new studies on the connection between hypertension and cognitive decline

(Oxford University Press USA) With the number of individuals affected by cognitive decline expected to rise over the next few decades, investigating its potential causes is of major public health interest. Two new studies published today in the Ameri...

'Hypertension' doesn't mean 'too much tension'

(Reuters Health) - Not everyone understands what “hypertension” means, and as a result, some patients may not take their blood pressure medications as directed or manage lifestyle factors effectively, a new paper suggests.

John Laragh, Hypertension-Therapy Pioneer, Dead at 90

His seminal discoveries involving the renin-angiotensin system helped shape the modern understanding of hypertension and its pharmacologic treatments. Heartwire from Medscape

Masked Uncontrolled Hypertension in Patients Treated for HTN

How "MUCH" masked uncontrolled hypertension occurs in patients who are treated for hypertension? European Heart Journal

Hypertension Treatment Vaccine On The Horizon

DNA vaccine which suppresses blood pressure-raising hormone has treated hypertension in rats. Next, human-based trials could take place

Pharmasmart exclusively recognized by American Society of Hypertension in new clinical guide

Michael JohnsenPharmaSmart was recognized as uniquely qualified among kiosks for use in the diagnosis and treatment of hypertension. read more

CDC: Hypertension-Related Mortality Has Climbed Since 2000

It has risen dramatically for the US as a whole and for men, women, and whites. Still, although it remains high for African Americans, their hypertension mortality fell during the same period. Heartwire from Medscape



Advertisement
 
Advertisement
 

News Quicklinks